Advertisement

Indikationsstellung und Technik der Brusterhaltenden Operation

  • F. Fitzal
  • M. Gnant
Chapter
  • 844 Downloads

Auszug

Die brusterhaltende Therapie (BET) beim Mammakarzinom gilt heute als Standard für die Mehrheit der betroffenen Patientinnen. Durch fortlaufende chirurgische Weiterentwicklungen, einen interdisziplinären Therapieansatz und lokaltherapeutische Qualitätskontrollmaßnahmen im Rahmen wissenschaftlicher Studien konnte die Rate an BET auch im multizentrischen Setting auf bis zu 73% gesteigert werden (Jakesz et al., 2003). An einzelnen hochspezialisierten Behandlungszentren liegt die BET-Rate sogar höher. Damit dieser hohe Standard erreicht und gehalten werden kann, bedarf es der engen koordinierten Zusammenarbeit verschiedener Ab — teilungen und Fachrichtungen. Im Falle der BET sind vor allem die Pathologie, die Radiologie, die internistische Onkologie und die Strahlentherapie als wesentliche Partner zu nennen. Regelmäßige gemeinsame Besprechungen schaffen einen kontinuierlichen Informationsaustausch und den wichtigen persönlichen Kontakt. Die Errungenschaft der BET ist also nicht nur eine Errungenschaft der Chirurgie, sondern vielmehr der immer wichtiger werdenden interdisziplinären Zusammenarbeit.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Al-Ghazal SK, Blamey RW, Stewart J, Morgan AA (1999 a) The cosmetic outcome in early breast cancer treated with breast conservation. Eur J Surg Oncol 25: 566–570PubMedCrossRefGoogle Scholar
  2. Al-Ghazal SK, Fallowfield L, Blamey RW (1999 b) Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol 25:571–573PubMedCrossRefGoogle Scholar
  3. Al-Ghazal SK, Fallowfield L, Blamey RW (1999 c) Patient evaluation of cosmetic outcome after conserving surgery for treatment of primary breast cancer. Eur J Surg Oncol 25:344–346PubMedCrossRefGoogle Scholar
  4. Atkins H, Hayward JL, Klugman DJ, Wayte AB (1972) Treatment of early breast cancer: a report after ten years of a clinical trial. Br Med J 2: 423–429PubMedCrossRefGoogle Scholar
  5. della Rovere GQ, Benson JR (2002) Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? Lancet Oncol 3: 183–187PubMedCrossRefGoogle Scholar
  6. Delouche G, Bachelot F, Premont M, Kurtz JM (1987) Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 13: 29–34PubMedGoogle Scholar
  7. EBCTCG (2002) Radiotherapy for early breast cancer. Cochrane Database Sys Rev 2002(2): CD003647Google Scholar
  8. Fisher B, Anderson S, Bryant J et al. (2002 a) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRefGoogle Scholar
  9. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002 b) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567–575PubMedCrossRefGoogle Scholar
  10. Fitzal F, Krois W, Trischler H, Wutzel L, Kühbelböck U, Wintersteiger B, Riedl O, Jakesz R, Gnant M, Wild T (2207a) The use of a breast symmetry index for objective evaluation of breast cosmesis. The Breast (in press)Google Scholar
  11. Fitzal F, Mader N, Rudas M et al. (2007 b) Intra-operative frozen section analyses during breast cancer operations: feasibility and advantages from 1.559 cases. Ann Surg Oncol (under review)Google Scholar
  12. Fitzal F, Riedl O, Wutzl L, Draxler W, Rudas M, Pluschnig U, Handl-Zeller L, Dubsky P, Bachleitner-Hofmann T, Steger G, Jakesz R, Gnant M (2007c) Breast-conserving surgery for T3/T4 breast cancer: An analysis of 196 patients. Breast Cancer Res Treat (in press)Google Scholar
  13. Freedman G, Fowble B, Hanlon A et al. (1999) Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005–1015PubMedCrossRefGoogle Scholar
  14. Gnant MFX, Poetter R, Kwasny W et al. (2005) Breast conservation without radiotherapy in low risk breast cancer patients — results of 2 prospective clinical trials of the Austrian Breast and Colorectal Cancer Study Group involving 1,518 postmenopausal patients with endocrine responsive breast cancer. San Antonio Breast Cancer Conference 2005, San AntonioGoogle Scholar
  15. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16: 1569–1583PubMedCrossRefGoogle Scholar
  16. Hall-Findlay EJ (1999) A simplified vertical reduction mammaplasty: shortening the learning curve. Plast Reconstr Surg 104: 748–759; discussion 760–763PubMedCrossRefGoogle Scholar
  17. Hengartner MO, Ellis RE, Horvitz HR (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494–499PubMedCrossRefGoogle Scholar
  18. Horst KC, Smitt MC, Goffinet DR, Carlson RW (2005) Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5: 425–438PubMedGoogle Scholar
  19. Huang E, Buchholz TA, Meric F et al. (2002) Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95: 2059–2067PubMedCrossRefGoogle Scholar
  20. Jakesz R, Gebhard B, Gnant M, Taucher S (1999) Indications and contraindications for breast preservation in patients with breast cancer. Chirurg 70: 394–399PubMedCrossRefGoogle Scholar
  21. Jakesz R, Hausmaninger H, Kubista E et al. (2002) Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer — Austrian Breast and Colorectal Cancer Study Group Trial 5. J Clin Oncol 20: 4621–4627PubMedCrossRefGoogle Scholar
  22. Jakesz R, Samonigg H, Gnant M et al. (2003) Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast and Colorectal Cancer Study Group. Ann Surg 237: 556–564PubMedCrossRefGoogle Scholar
  23. Keynes G (1981) Breast cancer: a case for conservation. Br Med J (Clin Res Ed) 282: 1392Google Scholar
  24. Khanna MM, Mark RJ, Silverstein MJ, Juillard G, Lewinsky B, Giuliano AE (1992) Breast conservation management of breast tumors 4 cm or larger. Arch Surg 127: 1038–1041PubMedGoogle Scholar
  25. Komoike Y, Akiyama F, Iino Y et al. (2005) Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 12: 104–111PubMedCrossRefGoogle Scholar
  26. Kurtz JM, Amalric R, Delouche G, Pierquin B, Roth J, Spitalier JM (1987) The second ten years: long-term risks of breast conservation in early breast cancer. Int J Radiat Oncol Biol Phys 13: 1327–1332PubMedGoogle Scholar
  27. Mc Kinnon N (1954) Control of cancer mortality. Lancet 266: 251–254PubMedCrossRefGoogle Scholar
  28. Mustakallio S (1972) Conservative treatment of breast carcinoma-review of 25 years follow up. Clin Radiol 23: 110–116PubMedCrossRefGoogle Scholar
  29. Noh WC, Paik NS, Kim MS et al. (2005) Ipsilateral breast tumor recurrence after breast-conserving therapy: a comparison of quadrantectomy versus lumpectomy at a single institution. World J Surg 29: 1001–1006PubMedCrossRefGoogle Scholar
  30. Park WW, Lees JC (1951) The absolute curability of cancer of the breast. Surg Gynecol Obstet 93: 129–152PubMedGoogle Scholar
  31. Pezner RD, Patterson MP, Hill LR et al. (1985 a) Breast retraction assessment: an objective evaluation of cosmetic results of patients treated conservatively for breast cancer. Int J Radiat Oncol Biol Phys 11: 575–578PubMedGoogle Scholar
  32. Pezner RD, Patterson MP, Hill LR, Vora NL, Desai KR, Lipsett JA (1985 b) Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma. Acta Radiol Oncol 24: 327–330PubMedGoogle Scholar
  33. Recht A, Connolly JL, Schnitt SJ et al. (1986) Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. Semin Oncol 13:434–449PubMedGoogle Scholar
  34. Rissanen PM (1969) A comparison of conservative and radical surgery combined with radiotherapy in the treatment of stage I carcinoma of the breast. Br J Radiol 42: 423–426PubMedGoogle Scholar
  35. Smitt MC, Nowels KW, Zdeblick MJ et al (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76: 259–267PubMedCrossRefGoogle Scholar
  36. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S (2005) Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241: 629–639PubMedCrossRefGoogle Scholar
  37. Thomsen K (1975) Possibilities and limits of breast conserving therapy of carcinoma. Arch Gynakol 219: 99–105PubMedCrossRefGoogle Scholar
  38. Touboul E, Buffat L, Belkacemi Y et al. (1999) Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43: 25–38PubMedGoogle Scholar
  39. Veronesi U, Banfi A, Del Vecchio M et al. (1986) Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol 22: 1085–1089PubMedCrossRefGoogle Scholar
  40. Veronesi U, Volterrani F, Luini A et al. (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26: 671–673PubMedCrossRefGoogle Scholar
  41. Veronesi U, Luini A, Del Vecchio M et al. (1993) Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328: 1587–1591PubMedCrossRefGoogle Scholar
  42. Veronesi U, Luini A, Galimberti V, Zurrida S (1994) Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18: 70–75PubMedCrossRefGoogle Scholar
  43. Veronesi U, Cascinelli N, Mariani L et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227–1232PubMedCrossRefGoogle Scholar
  44. Webb SJ, Harrison DJ, Wyllie AH (1997) Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol 41: 1–34PubMedCrossRefGoogle Scholar
  45. Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386–401PubMedGoogle Scholar

Copyright information

© Springer-Verlag / Wien 2007

Authors and Affiliations

  • F. Fitzal
    • 1
  • M. Gnant
    • 2
  1. 1.Brustambulanz AKH Wien, Universitätsklinik für ChirurgieMedizinische Universität WienWien
  2. 2.Universitätsklinik für ChirurgieMedizinische Universität WienWien

Personalised recommendations